Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ

$2.15

-$0.05 (2.05%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$2.13$2.24

Open $2.23

52 Week Range

$1.64$8.15

Previous Close $2.20

Market Cap714.79M

Volume8.69M

Avg Volume13.76M

P/E (TTM)-1.85

EPS (TTM)$-1.17

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$14.25

Based on 3 analysts (last year)

High Target

$40.00

Low Target

$2.00

Current

$2.15

Target

$14.25

$2.00$40.00

Potential upside of 561.25%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$5.17

3 analysts

All Time

$16.25

20 analysts

Analyst Consensus

Current Consensus

Buy

Based on 19 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
May 16, 2025	David Dai	UBS	$2.00	$1.66	+20.48%
Feb 28, 2025	Unknown	Piper Sandler	$6.00	$4.24	+41.51%
Jan 31, 2025	Joseph Catanzaro	Piper Sandler	$7.50	$5.85	+28.21%
Oct 24, 2024	David Dai	UBS	$17.00	$9.82

Recent Analyst Actions


Nov 24, 2025	Maintained	Barclays	Overweight	Overweight
Nov 6, 2025	Maintained	Chardan Capital	Buy	Buy
Oct 29, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Aug 19, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Aug 8, 2025	Maintained	Wells Fargo	Overweight	Overweight

Showing 1 to 5 of 224 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$14.25

Based on 3 analysts (last year)

High Target

$40.00

Low Target

$2.00

Current

$2.15

Target

$14.25

$2.00$40.00

Potential upside of 561.25%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$5.17

3 analysts

All Time

$16.25

20 analysts

Analyst Consensus

Current Consensus

Buy

Based on 19 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
May 16, 2025	David Dai	UBS	$2.00	$1.66	+20.48%
Feb 28, 2025	Unknown	Piper Sandler	$6.00	$4.24	+41.51%
Jan 31, 2025	Joseph Catanzaro	Piper Sandler	$7.50	$5.85	+28.21%
Oct 24, 2024	David Dai	UBS	$17.00	$9.82

Recent Analyst Actions


Nov 24, 2025	Maintained	Barclays	Overweight	Overweight
Nov 6, 2025	Maintained	Chardan Capital	Buy	Buy
Oct 29, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Aug 19, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Aug 8, 2025	Maintained	Wells Fargo	Overweight	Overweight

Showing 1 to 5 of 224 entries